Diagnostic delay in cerebral creatine deficiency disorders: lessons learned from a cross-sectional single center study, and guanidinoacetate and creatine measurements in Switzerland between 2015 and 2023
Abstract Background Cerebral creatine deficiency disorders (CCDD) are rare diseases caused by defects in the enzymes L-arginine: glycine amidinotransferase (AGAT) or guanidinoacetate-N-methyltransferase (GAMT), which are involved in synthesis of creatine; or by a defect in the creatine transporter (...
Saved in:
Main Authors: | Christina Kaufman, Anaïs D’Andrea, Annette Hackenberg, Martin Poms, Olivier Braissant, Johannes Häberle |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2025-01-01
|
Series: | Molecular and Cellular Pediatrics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40348-024-00188-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Successful management of refractory epilepsy in creatine transporter deficiency with cannabidiol and clobazam: A case report
by: Maria Borrell‐Pichot, et al.
Published: (2025-02-01) -
The Influence of Creatine Use on Performance of Swimmers
by: Hakan Acar, et al.
Published: (2018-12-01) -
The impact of creatine supplementation on the development of kidney disease – literature review
by: Mateusz Matczak, et al.
Published: (2025-02-01) -
Validation of a hypomorphic variant in CDK13 as the cause of CHDFIDD with autosomal recessive inheritance through determination of an episignature
by: Jan Fischer, et al.
Published: (2025-01-01) -
Sex-specific alterations in creatine metabolism in cellular compartments of peripheral blood leukocytes in type 1 diabetes
by: Nina Alchujyan, et al.
Published: (2024-12-01)